pHR_Gal4UAS_pGK_mCherry Citations (5)
Originally described in: Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors.Morsut L, Roybal KT, Xiong X, Gordley RM, Coyle SM, Thomson M, Lim WA Cell. 2016 Feb 11;164(4):780-91. doi: 10.1016/j.cell.2016.01.012. Epub 2016 Jan 28. PubMed Journal
Articles Citing pHR_Gal4UAS_pGK_mCherry
| Articles |
|---|
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.
Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, Walker WJ, McNally KA, Lim WA.
Cell. 2016 Oct 6;167(2):419-432.e16. doi: 10.1016/j.cell.2016.09.011. Epub 2016 Sep 29.
PubMed
Associated Plasmids |
| Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Tseng HC, Xiong W, Badeti S, Yang Y, Ma M, Liu T, Ramos CA, Dotti G, Fritzky L, Jiang JG, Yi Q, Guarrera J, Zong WX, Liu C, Liu D. Nat Commun. 2020 Sep 23;11(1):4810. doi: 10.1038/s41467-020-18444-2. PubMed |
| Validation of CRISPR activation system in Aedes cells using multicistronic plasmid vectors. Jaiswal V, Varghese SA, Ghosh S. Front Bioeng Biotechnol. 2023 Apr 19;11:1142415. doi: 10.3389/fbioe.2023.1142415. eCollection 2023. PubMed |
| ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma. Mahieu CI, Mancini AG, Vikram EP, Planells-Palop V, Joseph NM, Tward AD. Mol Cancer Res. 2024 Feb 1;22(2):152-168. doi: 10.1158/1541-7786.MCR-23-0746. PubMed |
| High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2. Chan CWF, Wang B, Nan L, Huang X, Mao T, Chu HY, Luo C, Chu H, Choi GCG, Shum HC, Wong ASL. Nat Biomed Eng. 2023 Nov 23. doi: 10.1038/s41551-023-01140-z. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.